Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
K.S. Lexina, N.Y. Timofeeva, V.S. Zadionchenko, G.G. Shehian, K.A. Aldushina
Chair of therapy and family medicine, Moscow State medico-stomatological University
The review is devoted to the modern data about mechanisms of cardiovascular dysfunction in patients suffering diabetes mellitus type 2, especially to the role of oxidative stress. It is determined that oxidative stress is involved in the development of myocardial ischemia, reperfusion-syndrome, endothelial dysfunction and atherogenesis. There are data that angiotensin converting enzyme inhibitor, zofenopril, has both cardio- and vasoprotective activities as well as antioxidative effect. These features are rationales to use it in patients with ischemic heart disease and diabetes mellitus.
Key words: myocardial infarction, diabetes mellitus, oxidative stress, zofenopril
Rational Pharmacother. Card. 2007; 2:53-58